Navigation Links
NCPA Statement on California's Delay of E-Pedigree Implementation
Date:3/26/2008

ALEXANDRIA, Va., March 26 /PRNewswire-USNewswire/ -- The California State Board of Pharmacy yesterday announced their intention to exercise their statutory authority to delay the implementation of E-Pedigree from January 1, 2009 to January 1, 2011. E-Pedigree is the new track and trace technology designed to strengthen the chain of custody for drugs by preventing diversions and counterfeit products from entering the marketplace.

The decision coincides with the recommendation that Dave Wilcox, RPh, owner of Northwest Medical Pharmacy in Fresno, Calif., offered in his testimony on behalf of the National Community Pharmacists Association (NCPA) before the Enforcement Committee of the California State Board of Pharmacy at their E-pedigree hearing back on December 5, 2007. (To view his entire testimony, please go to the following link: http://www.ncpanet.org/pdf/leg/testimony-pedigreewilcox20071204.pdf)

In response to the decision Bruce Roberts, RPh, executive vice president and CEO of the National Community Pharmacists Association (NCPA), issued the following statement:

"We applaud the California State Board of Pharmacy for their prudent decision to delay the implementation of E-Pedigree. While we certainly support the concept of using track and trace technology to limit the fraud and abuse of prescription drugs, the 2009 deadline was a logistical impossibility that lacked specificity for the affected parties. We hope the delay will allow those lingering issues to be addressed, including providing financial relief for community pharmacies that would be required to buy the expensive equipment for this unfunded mandate. The National Community Pharmacists Association remains committed to offering whatever assistance is needed to make the new 2011 implementation deadline as smooth and practical as possible."

The National Community Pharma
'/>"/>

SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. American Academy of Dermatology Issues Statement Urging the Public to be Sun Smart(SM)
2. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
3. Pelosi Statement on Social Security and Medicare Trustees Reports
4. Media Alert: Statement on the Report of the Trustees of Social Security and Medicare
5. Statement from Kent Hill, USAID Assistant Administrator for Global Health, on the Observance of World Tuberculosis Day 2008
6. Statement By Robert McSwain, Acting Director, Indian Health Service, Regarding National Native HIV/AIDS Awareness Day 2008
7. PCMA Statement on Comparative Effectiveness
8. Statement from Eli Lilly and Company: Response to Todays New York Times Article, Lilly E-Mail Discussed Off-Label Drug Use
9. Statement of Bernadette Toomey, President and Chief Executive Officer, American Lung Association
10. Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement
11. Position Statement Regarding Lt. Gov. Paterson from Tara A. Cortes, Ph.D, RN President and CEO of Lighthouse International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...mbudsman that they should respect the desire of pa...eiving emergency// contraception. A woman had alre...ked by the pharmacists while she was buying the Le...estions asked were with regard to the woman’s sexu...
... to be launched in the Indian city of Hyderabad, e...ology hub. // This will be a biotech incubation ce...acility which will come up to international standa...iotech firms, including several multinationals, ha...
...in the tissue environment of the breast that occur.... This study has found a place in the February iss...tages of pregnancy, lactation, and involution dict...f the human breast, resulting in multiplication, d...
...out the cancer causing potential of perfluorooctan...Teflon or non-stick cookware. // The concern was t...ittee for the Environmental Protection Agency said...otential. "The predominant panel view was that th...
Other Medicine News:Health News:Biotechnology Initiatives Planned In Hyderabad 2
(Date:9/3/2008)...atology Research and Education Foundation,s Withi...n Detecting, Treating and Unde...r the first time during its,unprecedented initiati...erican College of Rheumatology Research and Educat...ed from research funded by the Within Our,Reach: F...
(Date:9/3/2008)...l Vascular Disease Awareness Month, CHARLOTTESVIL...euticals,LLC, a clinical-stage drug-development co...of unmet medical needs, announced today that it ha...l trial of its lead drug,candidate trans sodium cr...,on the clinicaltrials.gov Website, is investigati...
(Date:9/3/2008).../- Panacea Pharmaceuticals,Inc. toda...13,737 covering,antibodies against human aspartyl ...ry human cancer biomarker and therapeutic target. ...ith the Massachusetts Institute of,Technology (MIT...his patent,for development of human cancer diagnos...
(Date:9/3/2008)...cuss Phase 3 Plans with FDA, PRINCETON, N.J., Sep...ounced today that it successfully completed two ke...y,s new, innovative low-dose, once-weekly,contrac...nternal product,code AG-200-15. The Phase 2b safet...endpoint of ovulation suppression, cycle control a...
Breaking Medicine Technology:New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2681 1Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2681 2Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2681 3Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2681 4Using additional biopsy scoring data may help determine prostate cancer prognosis 2676 1Using additional biopsy scoring data may help determine prostate cancer prognosis 2676 2Switching to MA Coverage Unlikely for Current Beneficiaries With MediGap or Medicare Only 2672 1Tobacco Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking 2667 1Tobacco Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking 2667 2
...tion of rapid, easy-to-use diagnostic tests, many ...rketplace to help clinicians assess dosage appropr...e presence of drugs of abuse. Some of these produc...st kits are suitable for point of care use by medi..., , Therapeutic drug monitoring measures the ...
...causes infectious mononucleosis (IM), is one of th... and most people become infected with EBV sometime... as 95 percent of adults between 35 and 40 years o...ies, including the U.S., infection with EBV most o... causing infectious mononucleosis in 35 percent to...
Other Medicine Technology:Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 2Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 3
...demand environments like OB/GYN, ER/Trauma, ICC/CC... delivers precision and control, plus consistent h...FESKIN* SATIN PLUS* Sterile Singles delive...excellent tactile sensitivity. The gloves are powd...
UROLOGY DRAPE. Soft translucent material for excellent shape conformity. Latex finger cot with additional adhesive ring around base. Full-width 50mm adhesive strip for secure fixing, with finger lift
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification
...the Penilab IV and the Penilab V have an exception...al studies. Model 1060 is similar to the Model 10...can one be added later. The Penilab V has a Doppl...of the accessories you'll need to get started. La...
Medicine Products: